Skip to main content


Scaling Microfluidics to Medical, Pharmaceutical and Biotech Applications

The µFlow Cell valorizes the R&D of a consortium between the µFlow Group of prof. Wim De Malsche of the Department of Chemical Engineering (CHIS) and Department of Bioengineering Sciences (DBIT) and prof. Karine Hellemans of the Diabetes Research Cluster (DRC) of the VUB. The µFlow Cell aspires cooperation with industry along three routes:
•    design and develop innovative microfluidic solutions within the core research lines of the consortium,
•    fabricate and validate microfluidic devices and microreactors, from prototype to small industrial series,
•    engineer and produce functional microparticles, such as biomaterials for therapeutic or diagnostic procedure, from lab to small industrial scale.